Downregulation of Erbin in Her2-overexpressing breast cancer cells promotes cell migration and induces trastuzumab resistance

Arteaga, 2012, Treatment of HER2-positive breast cancer: current status and future perspectives, Nature Reviews Clinical Oncology, 9, 16, 10.1038/nrclinonc.2011.177 Baselga, 2009, Novel anticancer targets: revisiting ERBB2 and discovering ERBB3, Nature Reviews Cancer, 9, 463, 10.1038/nrc2656 Bilder, 2000, Collective nomenclature for LAP proteins, Nature Cell Biology, 2, E114, 10.1038/35017119 Borg, 2000, ERBIN: a basolateral PDZ protein that interacts with the mammalian ERBB2/HER2 receptor, Nature Cell Biology, 2, 407, 10.1038/35017038 Bossinger, 2004, The apical disposition of the Caenorhabditis elegans intestinal terminal web is maintained by LET-413, Developmental Biology, 268, 448, 10.1016/j.ydbio.2004.01.003 Dai, 2006, Erbin inhibits RAF activation by disrupting the sur-8-Ras-Raf complex, Journal of Biological Chemistry, 281, 927, 10.1074/jbc.M507360200 Dan, 2010, Erbin, a negative regulator in diverse signal pathways, Current Protein and Peptide Science, 11, 759, 10.2174/138920310794557673 Dillon, 2002, Basolateral targeting of ERBB2 is dependent on a novel bipartite juxtamembrane sorting signal but independent of the C-terminal ERBIN-binding domain, Molecular and Cellular Biology, 22, 6553, 10.1128/MCB.22.18.6553-6563.2002 Ellenbroek, 2012, Cell polarity proteins and cancer, Seminars in Cancer Biology, 22, 208, 10.1016/j.semcancer.2012.02.012 Elsum, 2012, The Scribble-Dlg-Lgl polarity module in development and cancer: from flies to man, Essays in Biochemistry, 53, 141, 10.1042/bse0530141 Engelman, 2009, Targeting PI3K signalling in cancer: opportunities, challenges and limitations, Nature Reviews Cancer, 9, 550, 10.1038/nrc2664 Garrett, 2003, The crystal structure of a truncated ErbB2 ectodomain reveals an active conformation, poised to interact with other ErbB receptors, Molecular Cell, 11, 495, 10.1016/S1097-2765(03)00048-0 Huang, 2001, Erbin is a protein concentrated at postsynaptic membranes that interacts with PSD-95, Journal of Biological Chemistry, 276, 19318, 10.1074/jbc.M100494200 Huang, 2003, Erbin suppresses the MAP kinase pathway, Journal of Biological Chemistry, 278, 1108, 10.1074/jbc.M205413200 Hynes, 2005, ERBB receptors and cancer: the complexity of targeted inhibitors, Nature Reviews Cancer, 5, 341, 10.1038/nrc1609 Hynes, 2009, ErbB receptors and signaling pathways in cancer, Current Opinion in Cell Biology, 21, 177, 10.1016/j.ceb.2008.12.010 Izawa, 2002, ERBIN associates with p0071, an armadillo protein, at cell-cell junctions of epithelial cells, Genes to Cells, 7, 475, 10.1046/j.1365-2443.2002.00533.x Jaulin-Bastard, 2002, Interaction between Erbin and a Catenin-related protein in epithelial cells, Journal of Biological Chemistry, 277, 2869, 10.1074/jbc.M109652200 Jaulin-Bastard, 2001, The ERBB2/HER2 receptor differentially interacts with ERBIN and PICK1 PSD-95/DLG/ZO-1 domain proteins, Journal of Biological Chemistry, 276, 15256, 10.1074/jbc.M010032200 Junttila, 2009, Ligand-independent HER2/HER3/PI3K complex is disrupted by trastuzumab and is effectively inhibited by the PI3K inhibitor GDC-0941, Cancer Cell, 15, 429, 10.1016/j.ccr.2009.03.020 Kolch, 2003 Legouis, 2000, LET-413 is a basolateral protein required for the assembly of adherens junctions in Caenorhabditis elegans, Nature Cell Biology, 2, 415, 10.1038/35017046 Liu, 2012, c-Myb regulates cell cycle-dependent expression of Erbin: an implication for a novel function of Erbin, PLoS ONE, 7, e42903, 10.1371/journal.pone.0042903 Martin-Belmonte, 2012, Epithelial cell polarity, stem cells and cancer, Nature Reviews Cancer, 12, 23, 10.1038/nrc3169 Nagata, 2004, PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients, Cancer Cell, 6, 117, 10.1016/j.ccr.2004.06.022 Nakagawa, 2004, Analysis of the expression and localisation of a LAP protein, human scribble, in the normal and neoplastic epithelium of uterine cervix, British Journal of Cancer, 90, 194, 10.1038/sj.bjc.6601465 Rangwala, 2005, Erbin regulates mitogen-activated protein (MAP) kinase activation and MAP kinase-dependent interactions between Merlin and adherens junction protein complexes in Schwann cells, Journal of Biological Chemistry, 280, 11790, 10.1074/jbc.M414154200 Shi, 2011, The beta2-adrenergic receptor and Her2 comprise a positive feedback loop in human breast cancer cells, Breast Cancer Research and Treatment, 125, 351, 10.1007/s10549-010-0822-2 Shi, 2012, beta2-AR-induced Her2 transactivation mediated by Erbin confers protection from apoptosis in cardiomyocytes, International Journal of Cardiology Spector, 2009, Understanding the mechanisms behind trastuzumab therapy for human epidermal growth factor receptor 2-positive breast cancer, Journal of Clinical Oncology, 27, 5838, 10.1200/JCO.2009.22.1507 Stern, 2012, Improving treatment of HER2-positive cancers: opportunities and challenges, Science Translational Medicine, 4, 127rv122, 10.1126/scitranslmed.3001539 Thompson, 2004, Putting the rap on Akt, Journal of Clinical Oncology, 22, 4217, 10.1200/JCO.2004.01.103 Vivanco, 2002, The phosphatidylinositol 3-Kinase AKT pathway in human cancer, Nature Reviews Cancer, 2, 489, 10.1038/nrc839 Warner, 2003, Identification of three novel Smad binding proteins involved in cell polarity, FEBS Letters, 539, 167, 10.1016/S0014-5793(03)00155-8 Wu, 2010, Interaction between Ras(V12) and scribbled clones induces tumour growth and invasion, Nature, 463, 545, 10.1038/nature08702 Yuan, 2008, HER2-dependent MMP-7 expression is mediated by activated STAT3, Cellular Signalling, 20, 1284, 10.1016/j.cellsig.2008.02.017 Zhan, 2008, Deregulation of scribble promotes mammary tumorigenesis and reveals a role for cell polarity in carcinoma, Cell, 135, 865, 10.1016/j.cell.2008.09.045 Zhang, 2008, Overexpression, refolding, purification of Erbin PDZ domain from Escherichia coli and preparation of its polyclonal antibody, Preparative Biochemistry and Biotechnology, 38, 282, 10.1080/10826060802165105